Gabrielle Page‐Wilson

Institute for Family Health — United States

Medicine · Health Sciences

12h-index410citations36works8.72yr avg
OpenAlex↗ORCID↗Google Scholar↗Lab page↗

Accepting Students?

No reports yet. Know if this professor is taking students?

Research Topics

Pituitary Gland Disorders and Treatments(22), Growth Hormone and Insulin-like Growth Factors(11), Adrenal and Paraganglionic Tumors(9), Adrenal Hormones and Disorders(8), Glioma Diagnosis and Treatment(7)

Publications36 total

Unraveling A‐β+ ketosis‐prone diabetes: An evolving diagnosis with an elusive pathogenesis
Journal of Diabetes Investigation·2026Open Access
Genome-wide loss of heterozygosity predicts aggressive, treatment-refractory behavior in pituitary neuroendocrine tumors
Acta Neuropathologica·2024· 25 citedOpen Access
A medical chart audit to assess endocrinologist perceptions of the burden of endogenous Cushing’s syndrome
Pituitary·2024· 1 citedOpen Access
Holistic burden of illness in patients with endogenous Cushing's syndrome: A systematic literature review
Endocrinology Diabetes & Metabolism·2023· 2 citedOpen Access
SAT623 Everolimus For Treatment-refractory Prolactinomas
Journal of the Endocrine Society·2023Open Access
Ropinirole for the Treatment of Hyperprolactinemia: A Dose-Escalation Study of Efficacy and Tolerability
The Journal of Clinical Endocrinology & Metabolism·2023· 1 citedOpen Access
The treatment of aggressive prolactinomas with everolimus
Pituitary·2023· 12 citedOpen Access
Evaluating the burden of endogenous Cushing’s syndrome using a web-based questionnaire and validated patient-reported outcome measures
Pituitary·2023· 8 citedOpen Access
Increasing diversity, equity, and inclusion in the fields of nutrition and obesity: A roadmap to equity in academia
American Journal of Clinical Nutrition·2023· 5 citedOpen Access
Cushing Syndrome due to a Pancreatic Neuroendocrine Tumor Treated With Radiofrequency Ablation
JCEM Case Reports·2023· 4 citedOpen Access
Dopamine agonists for the treatment of pituitary tumours: From ergot extracts to next generation therapies
British Journal of Clinical Pharmacology·2023· 7 citedOpen Access
Dopamine Agonists for the Treatment of Pituitary Tumors: From Ergot Extracts to Next Generation Therapies
2022Open Access
Abstract #1173493: Patient-reported Burden of Illness in Endogenous Cushing’s Syndrome
Endocrine Practice·2022· 1 cited
Obesity is independently associated with septic shock, renal complications, and mortality in a multiracial patient cohort hospitalized with COVID-19
PLoS ONE·2021· 22 citedOpen Access
Pituitary corticotroph tumour with adrenocortical cells: A distinct clinicopathologic entity with unique morphology and methylation profile
Neuropathology and Applied Neurobiology·2021· 1 citedOpen Access
Pregnancy-specific Adaptations in Leptin and Melanocortin Neuropeptides in Early Human Gestation
The Journal of Clinical Endocrinology & Metabolism·2021· 6 citedOpen Access
74 Central cortisol regulation in pregnancy
American Journal of Obstetrics and Gynecology·2021Open Access
MON-282 Treatment of Hyperprolactinemia with Ropinirole: An Open-Label Dose Escalation Study
Journal of the Endocrine Society·2020· 2 citedOpen Access
MON-309 Prevalence of Silent Corticotroph Adenomas in a Large Cohort of Nonfunctioning Pituitary Adenomas: Plasma Proopiomelanocortin(POMC) Levels and Response to Pasireotide LAR
Journal of the Endocrine Society·2020· 1 citedOpen Access
Response to Letter to the Editor: “Assay-Specific Spurious ACTH Results Lead to Misdiagnosis, Unnecessary Testing, and Surgical Misadventure—A Case Series”
Journal of the Endocrine Society·2019· 1 citedOpen Access
page 1 of 2Next →

Frequent Co-authors

Sharon L. Wardlaw(10), Eliza B. Geer(9), Richard M. Smiley(7), Sunil K. Panigrahi(7), Alexander G. Khandji(5), Jeffrey N. Bruce(5), Kana Meece(5), Anne White(5), Judith Körner(4), Bhagyashree Oak(4), Abigail Silber(4), Pamela U. Freda(3), Andrew Lin(3), Viviane Tabar(3), Janetricks C. Okeyo(3), Matthew O’Hara(3), Amanda Tsang(3), Greene Lw(2), James W. Findling(2), Hershel Raff(2)